John F Sheridan

Director, PRESIDENT & CEO · 3 filings · Latest: May 29, 2026

TANDEM DIABETES CARE INC

Ticker	Owner	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Filing
TNDM	John F Sheridan	Director, PRESIDENT & CEO	May 15, 2026	Option Exercise	$0.00	51,189	—	170,051	May 19 8:06 PM
TNDM	John F Sheridan	Director, PRESIDENT & CEO	Feb 17, 2026	Option Exercise	$0.00	11,454	—	127,091	Feb 19 9:34 PM